Cutting-edge immunotherapy treatment approved for another deadly cancer – New Haven Register
|
Cutting-edge immunotherapy treatment approved for another deadly cancer
New Haven Register The FDA approval is the latest step forward for the fast-moving field of immunotherapy, which aims to bolster the immune system to attack malignancies. CAR T-cell therapies are among several approaches, along with treatments called checkpoint … |
